絞り込み

16640

広告

Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).

著者 Liem KS , Fung S , Wong DK , Yim C , Noureldin S , Chen J , Feld JJ , Hansen BE , Janssen HLA
Gut.2019 Aug 28 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (11view , 0users)

Full Text Sources

Medical

Although most patients with chronic hepatitis B (CHB) reach effective virological suppression with long-term nucleos(t)ide analogues (NA) therapy, some might not need to continue treatment for life. In this randomised, controlled, phase IV trial, we evaluated off-therapy outcomes in patients after discontinuing long-term NA therapy.
PMID: 31462554 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード